These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37792095)

  • 1. Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals.
    Letafati A; Mozhgani SH; Marjani A; Amiri A; Siami Z; Mohammaditabar M; Molaverdi G; Hedayatyaghoobi M
    Med Oncol; 2023 Oct; 40(11):317. PubMed ID: 37792095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study.
    Zarei Ghobadi M; Emamzadeh R; Teymoori-Rad M; Mozhgani SH
    Virol J; 2021 Aug; 18(1):175. PubMed ID: 34446027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
    Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
    BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals.
    Letafati A; Bahavar A; Norouzi M; Rasouli A; Hedayatyaghoubi M; Molaverdi G; Mozhgani SH; Siami Z
    BMC Res Notes; 2024 Aug; 17(1):222. PubMed ID: 39127702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
    Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
    Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
    Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
    J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL).
    Ahmadi Ghezeldasht S; Blackbourn DJ; Mosavat A; Rezaee SA
    Crit Rev Clin Lab Sci; 2023 May; 60(3):189-211. PubMed ID: 36593730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
    Zarei Ghobadi M; Emamzadeh R
    PLoS One; 2022; 17(1):e0262739. PubMed ID: 35041720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).
    Zarei-Ghobadi M; Sheikhi M; Teymoori-Rad M; Yaslianifard S; Norouzi M; Yaslianifard S; Faraji R; Farahmand M; Bayat S; Jafari M; Mozhgani SH
    BMC Res Notes; 2021 Mar; 14(1):109. PubMed ID: 33757561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation.
    Letafati A; Bahavar A; Tabarraei A; Norouzi M; Amiri A; Mozhgani SH
    Infect Agent Cancer; 2024 May; 19(1):23. PubMed ID: 38734673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of p12K and p12R alleles of HTLV Type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers.
    Martins ML; Soares BC; Ribas JG; Thorun GW; Johnson J; Kroon EG; Carneiro-Prioetti AB; Bonjardim CA;
    AIDS Res Hum Retroviruses; 2002 Sep; 18(13):899-902. PubMed ID: 12230932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-lymphotropic virus 1 (HTLV-1) pathogenesis: A systems virology study.
    Mozhgani SH; Zarei-Ghobadi M; Teymoori-Rad M; Mokhtari-Azad T; Mirzaie M; Sheikhi M; Jazayeri SM; Shahbahrami R; Ghourchian H; Jafari M; Rezaee SA; Norouzi M
    J Cell Biochem; 2018 May; 119(5):3968-3979. PubMed ID: 29227540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.